Gilead Sciences Inc. GILD, -1.08% and biotech Goldfinch Bio Inc. are striking a deal to develop and commercialize a pipeline of drugs for kidney diseases, the companies announced Wednesday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,